NDC 49288-0496

Desert Sage

Desert Sage

Desert Sage is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Artemisia Tridentata Pollen.

Product ID	49288-0496_8b59a012-60d1-4fa4-9ee7-fe89524760a2
NDC	49288-0496
Product Type	Human Prescription Drug
Proprietary Name	Desert Sage
Generic Name	Desert Sage
Dosage Form	Injection, Solution
Route of Administration	INTRADERMAL; SUBCUTANEOUS
Marketing Start Date	1992-04-13
Marketing Category	BLA / BLA
Application Number	BLA102223
Labeler Name	Antigen Laboratories, Inc.
Substance Name	ARTEMISIA TRIDENTATA POLLEN
Active Ingredient Strength	0 g/mL
Pharm Classes	Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS]
NDC Exclude Flag	E
Listing Certified Through	2017-12-31

Packaging

NDC 49288-0496-1

2 mL in 1 VIAL, MULTI-DOSE (49288-0496-1)

Marketing Start Date	1992-04-13
NDC Exclude Flag	N
Sample Package?	N

NDC SPL Data Element Entries

NDC 49288-0496-5 [49288049605]

Desert Sage INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1992-04-13
Inactivation Date	2019-10-21

NDC 49288-0496-4 [49288049604]

Desert Sage INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1992-04-13
Inactivation Date	2019-10-21

NDC 49288-0496-1 [49288049601]

Desert Sage INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1992-04-13
Inactivation Date	2019-10-21

NDC 49288-0496-2 [49288049602]

Desert Sage INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1992-04-13
Inactivation Date	2019-10-21

NDC 49288-0496-3 [49288049603]

Desert Sage INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1992-04-13
Inactivation Date	2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ARTEMISIA TRIDENTATA POLLEN	.1 g/mL

OpenFDA Data

SPL SET ID:	b8e9933d-eeb3-4379-aaa4-5dfb1179683f
Manufacturer	Antigen Laboratories, Inc.
UNII	1EDY616508 U2AI3H2J5Y 92N6W6KO2G BML0J15H8W 380W4HYR6N GG8WX068MX YB1308W43O ZIO18VN6HJ 644CZ16IR5 098LKX5NCN DO87T1U2CI G515RAI9FY R6H8O3GVL9 UVC3Z60VTX YI19RB8YFD JQ87AA60GU 5AN5LR8L3F K20Y81ACO3 81GS97HVFO RX18M46K8L 86LWA5503I 2MH135KC6G V825XJG64G 1GH3WV23KH 2QOF601J1M M3S672G75O WIB701MW2H WQ3S5294XY N52MIQ81ZW 63TBJ590BL O4AB4546TP DNB59M1NVU 26U0BU8G83 B67NF86HF0 57KIJ4772H ANT994T71D KU1V1898XX UU78E56M7L 13KFG30UBR 28D6K7E9IP 73B14PX5FW
RxNorm Concept Unique ID - RxCUI	1014742 851933 852049 1014746 851937 852512 1014339 852554 852596 1014705 852535 995746 852082 852542 852240 897378 897506 897319 899534 851929 995611 896120 898010 852010 898329 851988 852014 851984 1232608 1014769 896224 852032 1115931 852216 896249 852212 852745 851941 897953 852077 852099 897307 852090 1098396 1006353 1117086 885753 897991 895729 1115927 895922 1006498 852001 1014450 852161 897394 851972 852023 896259 901035 995604

Pharmacological Class

Non-Standardized Pollen Allergenic Extract [EPC]
Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Pollen [CS]
Allergens [CS]

NDC Crossover Matching brand name "Desert Sage" or generic name "Desert Sage"

NDC	Brand Name	Generic Name
49288-0496	Desert Sage	Desert Sage
49288-0497	Desert Sage	Desert Sage

Trademark Results [Desert Sage]

Mark Image Registration \| Serial	Company Trademark Application Date
DESERT SAGE 77864332 3810194 Dead/Cancelled	Desert Sage II LLC 2009-11-03
DESERT SAGE 76139516 2490709 Dead/Cancelled	Desert Sage II LLC 2000-10-03
DESERT SAGE 73829531 1641002 Dead/Cancelled	ARAMIS INC. 1989-10-05

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.